[Pralidoxime prevents certain teratogenic effects induced by bidrin in quail embryos].
Bidrin treatment of quail embryos results in axial anomalies as well as malformations of the beak and the limbs. Whereas the administration of pralidoxime to teratogen-treated embryos prevents the appearance of the axial anomalies, the morphogenesis of the beak and limbs remains profoundly altered.
D000014:Abnormalities, Drug-Induced / Q000196:embryology*; D000818:Animals; D001502:Beak / Q000002:abnormalities; D002800:Cholinesterase Inhibitors; D009333:Neck / Q000002:abnormalities; D009943:Organophosphorus Compounds / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D011220:Pralidoxime Compounds / Q000494:pharmacology*; D013576:Syndactyly / Q000139:chemically induced
D002800:Cholinesterase Inhibitors; D009943:Organophosphorus Compounds; D011220:Pralidoxime Compounds
Prévention par la pralidoxime de certains effets tératogènes induits par le bidrin chez l'embryon de caille